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Abstract
Antioxidants can scavenge highly reactive radicals. As a result the antioxidants are converted into oxidation products that
might cause damage to vital cellular components. To prevent this damage, the human body possesses an intricate network
of antioxidants that pass over the reactivity from one antioxidant to another in a controlled way. The aim of the present
study was to investigate how the semi-synthetic flavonoid 7-mono-O-(b-hydroxyethyl)-rutoside (monoHER), a potential
protective agent against doxorubicin-induced cardiotoxicity, fits into this antioxidant network. This position was compared
with that of the well-known flavonoid quercetin. The present study shows that the oxidation products of both monoHER
and quercetin are reactive towards thiol groups of both GSH and proteins. However, in human blood plasma, oxidized
quercetin easily reacts with protein thiols, whereas oxidized monoHER does not react with plasma protein thiols. Our results
indicate that this can be explained by the presence of ascorbate in plasma; ascorbate is able to reduce oxidized monoHER to
the parent compound monoHER before oxidized monoHER can react with thiols. This is a major difference with oxidized
quercetin that preferentially reacts with thiols rather than ascorbate. The difference in selectivity between monoHER and
quercetin originates from an intrinsic difference in the chemical nature of their oxidation products, which was corroborated
by molecular quantum chemical calculations. These findings point towards an essential difference between structurally
closely related flavonoids in their interplay with the endogenous antioxidant network. The advantage of monoHER is that it
can safely channel the reactivity of radicals into the antioxidant network where the reactivity is completely neutralized.
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Introduction
The human body is endowed with a wide range of antioxidants
to protect cells from damage induced by free radicals and other
reactive species. Glutathione (GSH) is one of the most important
endogenous hydrophilic antioxidants [1]. It is synthesized in many
different cell types from its constituting amino acids glutamic acid,
cysteine and glycine, and is therefore not required in the human
diet [1]. The actual antioxidant property of GSH is attributable to
the thiol group that is present in its cysteine moiety. As an effective
nucleophile, GSH also plays an important role in the protection
against electrophilic compounds [2].
Like GSH, ascorbic acid (vitamin C) is also an important
hydrophilic antioxidant. In contrast to GSH, ascorbic acid cannot
be synthesized by humans and, as a consequence, is required in
the human diet [3]. It directly scavenges O2
N2 and
NOH and
various other radicals.
Phenolic antioxidants comprise a-tocopherol (the most active
form of vitamin E) and flavonoids. Like ascorbic acid and most
other vitamins, a-tocopherol has to be obtained exclusively from
the diet. It is the major lipid-soluble lipoprotein antioxidant [4]. a-
Tocopherol is localized in biomembranes and functions as an
efficient inhibitor of lipid peroxidation. Flavonoids, on the other
hand, are not essential nutrients but they form an integral part of
the human diet as they are found in fruits, vegetables, nuts and
plant-derived beverages such as tea and wine [5,6]. They have a
wide range of biological activities [7,8,9], but are most commonly
known for their antioxidant activity. Quercetin is one of the most
frequently studied dietary flavonoids [5,10]. It can scavenge highly
reactive species, an activity that is implicated in its health benefits
[11,12].
The flavonoid of interest to us, that closely resembles the
chemical structure of quercetin, is the semi-synthetic flavonoid 7-
mono-O-(b-hydroxyethyl)-rutoside (monoHER). MonoHER is the
most powerful antioxidant constituent of the registered drug
VenorutonH [13], which is used in the treatment of chronic venous
insufficiency [14]. In vitro screening has shown that monoHER is
the most potent protector against cardiotoxicity induced by the
anticancer agent doxorubicin within a series of flavonoids [13].
Preclinical experiments have confirmed that monoHER is indeed a
potential protective agent against doxorubicin-induced cardiotox-
icity [15,16]. Because of these promising results, clinical trials are
being performed to study the protection of intravenously admin-
istered monoHER against doxorubicin-induced cardiotoxicity in
cancer patients [17,18]. The antioxidant activity of monoHER is
supposed to be involved in its protection. Because of its excellent
radical scavenging properties monoHER can effectively protect the
heart against free radicals produced by doxorubicin.
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donate an electron or a hydrogen atom to the radical involved,
thereby converting the radical into a relatively stable non-radical.
In this way the reactivity of the radical is annihilated. However, in
this reaction the antioxidant itself is converted into an oxidation
product that takes over part of the reactivity of the radical. This
oxidized antioxidant might cause damage to vital cellular
components [19]. For example, when a-tocopherol scavenges free
radicals it is oxidized to produce the corresponding tocopheroxyl
radicals [20]. These radicals can recombine with other radicals,
such as peroxyl radicals, thereby neutralizing them [21]. However,
when these tocopheroxyl radicals cannot be eliminated, lipid
peroxidation is aggravated, a phenomenon referred to as
tocopherol-mediated peroxidation [21,22].
To prevent damage by reactive oxidation products of
antioxidants, the human body has a refined network of
antioxidants that pass over the reactivity from one antioxidant to
another in a controlled way, thereby gradually diminishing the
reactivity of the radical and recycling the antioxidants. In this way,
it has been shown that ascorbate can regenerate a-tocopherol from
tocopheroxyl radicals, thereby preventing tocopherol-mediated
peroxidation [4,20,23]. This illustrates that antioxidants act in
synergy to annihilate radicals. Besides preventing damage induced
by harmful oxidation products, regeneration is important because
it restores the antioxidant network.
The regeneration of a-tocopherol by ascorbate is well
documented, however, not much is known on the regeneration
of flavonoids. When quercetin protects against free radicals, thiol-
reactive oxidation products of quercetin are formed that can cause
damage to vital cellular components, a phenomenon known as the
quercetin paradox [24]. Recently it was found that the oxidation
product of monoHER is also reactive towards thiols [25]. This
might have implications for the applicability of monoHER.
However, as mentioned above, antioxidants do not act in isolation
to protect against oxidative damage.
The aim of the present study was to determine how monoHER
fits into the antioxidant network and to get insight in the
regeneration of flavonoids. Particularly, the reactivity of oxidized
monoHER towards thiols and ascorbate was investigated. In
addition a comparison with quercetin was made.
Materials and Methods
Ethics Statement
For the study spare, anonymised human blood plasma obtained
from the Academic Hospital Maastricht was used according to the
procedure approved by the medical ethical review board of the
hospital.
Chemicals
7-mono-O-(b-hydroxyethyl)-rutoside (monoHER) was kindly
provided by Novartis Consumer Health (Nyon, Switzerland).
Stock solutions of the drug were freshly prepared in a methanol/
25 mM phosphate buffer (pH 3.33) mixture (4/1, v/v). Quercetin
was purchased from Sigma (St. Louis, MO, USA) and stock
solutions were freshly prepared in methanol. Bovine serum
albumin (BSA), reduced glutathione (GSH), hydrogen peroxide
(H2O2), horseradish peroxidase (HRP), L-ascorbic acid (vitamin C)
and 5,59-dithiobis-(2-nitrobenzoic acid) (DTNB) were also pur-
chased from Sigma (St. Louis, MO, USA). Trifluoroacetic acid
(TFA) was acquired from Sigma-Aldrich (Steinheim, Germany).
Acetonitrile HPLC grade and methanol were obtained from
Biosolve (Valkenswaard, The Netherlands). 29-GSH-monoHER
was synthesized as described previously [25].
Oxidation of monoHER
MonoHER was oxidized as described before [25]. Shortly,
50 mM monoHER was incubated for 5 minutes at 37uC together
with 1.6 nM HRP and 33 mMH 2O2 in a 145 mM phosphate
buffer (pH 7.4). The GSH-monoHER adduct was formed by
oxidizing 50 mM monoHER in the presence of 40 mM GSH. To
investigate the influence of ascorbate on the oxidation of
monoHER and on the formation of the GSH-monoHER adduct,
ascorbate (final concentration of 40 mM, unless noted otherwise)
was added to the incubation mixtures. The reactions were
monitored spectrophotometrically and by HPLC. MonoHER
consumption was determined at 355 nm, ascorbate consumption
at 270 nm.
Spectrophotometric analysis
Spectrophotometric analysis was performed with a Varian
Carry 50 spectrophotometer (Varian, Mulgrave, VIC, Australia).
All absorption spectra were recorded from 220 to 500 nm with a
scan speed of 960 nm/min, using quartz cuvettes. The UV/Vis
scans were started 30, 150 and 300 seconds after the addition of
HRP.
High-performance liquid chromatography analysis
High-performance liquid chromatography (HPLC) was per-
formed using a HP 1100 series HPLC system (Agilent Technol-
ogies, Palo Alto, CA, USA). Analytical separations were achieved
using a Supelcosil LC 318 column (5 mm, 25 cm 6 4.6 mm)
(Supelco, Bellefonte, PA, USA). The mobile phase consisted of
water containing 0.1% (v/v) TFA with linear gradients of 5%
acetonitrile at t=0 to 20% acetonitrile at 5 min followed by an
increase to 30% acetonitrile at 10 min. Finally 90% acetonitrile
was used from 18 min onward for 5 min. The column was
reequilibrated with 5% acetonitrile for 5 min. A flow rate of 2 ml/
min and an injection volume of 20 ml were used. Detection was
carried out with a diode array detector (DAD). The chromato-
grams presented are based on detection at 355 nm (absorption
maximum of monoHER).
Measurement of thiol reactivity
To determine the thiol reactivity of oxidized monoHER and
quercetin, free SH-groups were measured using the DTNB [5, 59-
dithiobis-(2-nitrobenzoic acid)] assay. The incubation mixtures
contained 50 mM monoHER, 1.6 nM HRP, 33 mMH 2O2 and
40 mM GSH (or 400 mM BSA) in a 145 mM phosphate buffer
(pH 7.4). When the oxidation was performed in the presence of
ascorbate, the incubation mixture additionally contained 40 mMo f
ascorbate. After 0 or 5 minutes of incubation at 37uC, thiol
content was measured by adding DTNB (final concentration of
0.6 mM) to the incubation mixtures. The formation of TNB was
measured spectrophotometrically at 412 nm. Similar experiments
with 50 mM monoHER were performed in human blood plasma
to determine the reactivity towards plasma protein thiols. Identical
experimental conditions were used to determine thiol reactivity of
oxidized quercetin.
Molecular quantum chemical calculations
Molecular quantum chemical calculations (ab initio level) were
performed with the software program Spartan ’06 (Wavefunction,
Irvine, CA, USA) to corroborate the experimental results. The
Møller Plesset, RI-MP2 with the 6-31G* basis set was used to
calculate the relative abundance of the tautomers of oxidized
quercetin. The Hartree-Fock method with the 3-21G basis set was
used for calculating the equilibrium geometry and the energies of
The Antioxidant Network
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quinone methide and a simplified monoHER quinone (the rutin
group at C3-O and the ethoxygroup at C7-O were replaced by
methyl groups) and the highest occupied molecular orbital
(HOMO) of GSH and ascorbate, unless depicted otherwise. In
addition, a LUMO map for the monoHER quinone and the
quercetin quinone methide were generated to get a visual on the
LUMO distribution.
Statistics
All experiments were performed, at least, in triplicate. Data are
expressed as mean 6 SD or as a typical example. Statistical
analysis was performed using student’s t-test. P values #0.05 were
considered statistically significant.
Results
GSH reacts with oxidized monoHER to form 29-GSH-
monoHER
UV and HPLC analysis (Fig. 1A and Fig. 2A) show that
oxidation of 50 mM monoHER by HRP/H2O2 leads to the
consumption of monoHER at a rate of 5.560.4 mM/min (Fig. 3).
In the presence of 40 mM GSH, all the oxidized monoHER is
recovered as 29-GSH-monoHER at a rate of 5.560.3 mM/min
(Fig. 3). This is concluded from the appearance of the
characteristic UV spectrum of 29-GSH-monoHER (Fig. 1B) and
HPLC analysis of the incubation mixture (Fig. 2B). In the HPLC
chromatogram a second peak emerges, eluting at a position
identical to that of the synthesized 29-GSH-monoHER adduct.
These data demonstrate that the monoHER quinone is formed as
a primary oxidation product and that this oxidation product forms
an adduct with GSH.
Ascorbate reduces oxidized monoHER to monoHER
As shown by UV and HPLC analysis, addition of 40 mM
ascorbate to the incubation mixture containing monoHER and
HRP/H2O2 prevents monoHER consumption (Fig. 1C and
Fig. 2C). At the same time the ascorbate concentration decreases,
as seen in the spectrum as a decrease of the absorption at 270 nm.
When monoHER is omitted from the incubation mixture, there is
no detectable ascorbate consumption. These findings suggest that
monoHER is regenerated from its oxidation product by ascorbate.
The average rate of ascorbate consumption in the presence of
monoHER (4.360.3 mM/min) is 23% less than monoHER
consumption in the absence of ascorbate (5.560.4 mM/min)
(Fig. 3). Addition of more ascorbate (final concentration of
100 mM) to the incubation mixture reduces the ascorbate
consumption to 1.560.1 mM/min, 72% less than monoHER
consumption without ascorbate. This indicates that the enzyme
HRP is also partially inhibited by ascorbate, as has been shown
previously [26]. The extent of inhibition depends on the ascorbate
concentration.
Competition between GSH and ascorbate for oxidized
monoHER
To investigate the competition between GSH and ascorbate,
monoHER was oxidized in the presence of both compounds
(Fig. 1D and Fig. 2D). Comparison of the rate of 29-GSH-
monoHER formation (1.360.1 mM/min) and the rate of ascor-
bate consumption (3.060.3 mM/min) (Fig. 3) indicates that
oxidized monoHER reacts two to three times faster with ascorbate
than with GSH. These results are in contrast with those found for
quercetin. In a comparable competition experiment with quercetin
it was found that oxidized quercetin predominantly reacts with
GSH [26].
Figure 1. Spectrophotometrical analyses. Spectrophotometrical analysis of the incubation mixture containing (A) 50 mM monoHER, 1.6 nM
horseradish peroxidase (HRP) and 33 mMH 2O2. The same experiment was carried out in (B) the presence of 40 mM GSH, (C) 40 mM ascorbate and (D)
both 40 mM GSH and 40 mM ascorbate. The UV/Vis scans were recorded 30, 150 and 300 seconds after the addition of HRP. A typical example is
shown.
doi:10.1371/journal.pone.0013880.g001
The Antioxidant Network
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quercetin, produced in situ by HRP/H2O2-mediated oxidation,
decrease the thiol content of the incubation mixture containing
40 mM GSH to approximately 50% in 5 minutes. The presence of
ascorbate (40 mM) does not affect the consumption of thiols by
oxidized quercetin (Fig. 4B). In contrast, ascorbate significantly
decreases the thiol consumption induced by oxidized monoHER
(Fig. 4B). This confirms that oxidized monoHER preferentially
reacts with ascorbate, whereas oxidized quercetin preferentially
reacts with GSH.
Competition between protein thiols and ascorbate for
oxidized monoHER and oxidized quercetin
Next, monoHER and quercetin were oxidized in human blood
plasma. In human blood plasma GSH is practically absent and
ascorbate concentrations are 40–60 mM [27]. The generation of
oxidized quercetin decreases the thiol content of plasma, i.e.
protein thiols, by approximately 40% (Fig. 4C). In contrast, the
generation of oxidized monoHER has no effect on the thiol
content of human blood plasma (Fig. 4C). An additional
experiment shows that oxidized monoHER is able to react with
the thiol group of albumin, which is the most abundant plasma
protein (Fig. 4D). Ascorbate is able to prevent the reaction of
oxidized monoHER with albumin (Fig. 4D).
These results point towards an essential difference between
monoHER and quercetin, i.e. oxidized monoHER rather reacts
with ascorbate than with protein thiols, while oxidized quercetin
preferentially reacts with protein thiols.
Explanation of the difference in reactivity between
oxidized monoHER and oxidized quercetin
Molecular quantum chemical calculations show that the
tautomer depicted in Fig. 5A, a quinone methide, represents
Figure 2. HPLC analyses. HPLC analysis of the incubation mixture containing (A) 50 mM monoHER, 1.6 nM horseradish peroxidase (HRP) and
33 mMH 2O2. The same experiment was carried out in (B) the presence of 40 mM GSH, (C) 40 mM ascorbate and (D) both 40 mM GSH and 40 mM
ascorbate. The different incubation mixtures were injected on the HPLC system 5 minutes after the addition of HRP. A typical example is shown. The
retention time of monoHER is 6.7 min and that of 29-GSH-monoHER is 5.4 min. The initial peak height of monoHER before oxidation was 88 mAU,
corresponding to a concentration of 50 mM. After 5 min of oxidation the monoHER concentrations in the incubation mixtures A, B, C and D were
22.5 mM, 22.5 mM, 50 mM and 43.5 mM, respectively.
doi:10.1371/journal.pone.0013880.g002
Figure 3. MonoHER and ascorbate consumption rates. Con-
sumption of monoHER and ascorbate in the incubation mixtures
containing 50 mM monoHER, 1.6 nM HRP and 33 mMH 2O2 in the
presence of either 40 mM GSH, 40 mM ascorbate or both 40 mM GSH and
40 mM ascorbate. The incubation time was 5 minutes. All measurements
were carried out in triplicate and data are expressed as mean 6 SD.
doi:10.1371/journal.pone.0013880.g003
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the ortho-quinone, illustrated in Fig. 5B, can be formed.
Generation of a LUMO map of oxidized monoHER and oxidized
quercetin shows that the LUMO of oxidized monoHER is
restricted to the B ring and part of the C ring, while the LUMO of
oxidized quercetin is delocalized over all the phenolic rings (Fig. 5).
The LUMO of the monoHER ortho-quinone and the quercetin
quinone methide are 42.6 kJ/mol and 0.0605 kJ/mol, respective-
ly, showing that oxidized monoHER is a harder electrophile than
oxidized quercetin. The HOMO of ascorbate and GSH are
2394 kJ/mol and 21.35 kJ/mol, respectively, showing that
ascorbate is a harder nucleophile than GSH. According to
Pearson’s HSAB concept [28], hard electrophiles react faster
and form stronger bonds with hard nucleophiles, explaining the
preferential reaction of oxidized monoHER with ascorbate over
thiols.
Discussion
Paradoxically, free radical scavenging antioxidants are chemi-
cally converted into potentially harmful oxidation products when
they protect against free radicals [29]. These oxidation products
Figure 4. Reactivity of oxidized monoHER and oxidized quercetin towards thiols. Thiol content of the incubation mixture containing
50 mM monoHER or quercetin, 1.6 nM HRP and 33 mMH 2O2 in the presence of either (A) 40 mM GSH, (B) both 40 mM GSH and 40 mM ascorbate, (C)
human blood plasma or (D) 400 mM albumin (BSA) (with or without 40 mM ascorbate). The thiol content of the different incubation mixtures was
measured 5 minutes after the addition of HRP. All measurements were carried out in triplicate and data are expressed as mean 6 SD. *P,0.05
compared to control.
doi:10.1371/journal.pone.0013880.g004
Figure 5. LUMO delocalization maps. LUMO delocalization map of (A) oxidized quercetin and (B) oxidized monoHER. In oxidized monoHER, the
rutin group at C3-O and the ethoxygroup at C7-O were replaced by methyl groups and for quercetin, the most abundant tautomer (.99%) was used.
The LUMO of oxidized monoHER is localized in the B ring and part of the C ring, while the LUMO of oxidized quercetin is distributed over all the
phenolic rings (rings A, C and B).
doi:10.1371/journal.pone.0013880.g005
The Antioxidant Network
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scavenged, and might therefore cause damage to vital cellular
targets [19,30]. To protect cells against this damage the human
body has a refined network in which the reactivity is transferred
from one antioxidant to another, thereby gradually diminishing
the reactivity [1,29].
The aim of the present study was to investigate how monoHER
fits into this endogenous antioxidant network. The interaction of
monoHER with the network was compared with that of quercetin,
which chemically closely resembles monoHER. The results of this
study show that oxidized monoHER is reduced by ascorbate to
recycle the parent compound monoHER, while oxidized mono-
HER reacts with GSH to form a GSH-conjugate. The reactions of
oxidized quercetin with ascorbate and GSH are similar to those of
oxidized monoHER [26]. However, as shown in the present study,
a major difference is that oxidized quercetin preferentially reacts
with thiols, whereas oxidized monoHER preferentially reacts with
ascorbate. This is an essential difference in the interplay of both
flavonoids with antioxidants of the endogenous antioxidant
network.
The different position of monoHER and quercetin in the
network has to originate from an intrinsic difference in the
chemical nature of their oxidation products. Quantum chemical
calculations revealed that of the four possible tautomeric forms of
oxidized quercetin, the tautomer shown in Fig. 5A, has an
abundance of more than 99%. In this tautomer the distance
between the electron deficient carbonyl centers is maximal, which
is energetically favorable and explains its high abundance. The
high abundance of this specific tautomer is corroborated by the
formation of adducts in the A ring, i.e. 6-GSH-quercetin and 8-
GSH-quercetin, in the reaction of GSH with oxidized quercetin
[31].
In monoHER a rutinose is attached to the 3-OH group of the C
ring and a hydroxyethyl group is attached to the hydroxyl group
oxygen at position 7 of the A ring. These substitutions preclude the
formation of quinone methide tautomers in oxidized monoHER.
Therefore, only the ortho-quinone can be formed (Fig. 5B). In this
ortho-quinone two carbonyls are adjacent, which is energetically
unfavorable compared to the larger distance between these groups
in the preferential tautomer of oxidized quercetin. The presence of
an ortho-quinone in the B ring is corroborated by the formation of
an adduct in this ring, i.e. 29-GSH-monoHER, in the reaction of
oxidized monoHER with GSH [25].
Apparently, the oxidation products of monoHER and quercetin
are energetically different. The LUMO of oxidized monoHER is
primarily concentrated in the B ring and therefore relatively high,
Figure 6. Chemical reaction of oxidized monoHER with ascorbate. (A) Chemical structure of oxidized monoHER (left) and ascorbate (right).
The active part of ascorbate and the active part of oxidized monoHER are indicated by the red ellipses. (B) Suggested route for the reaction of
oxidized monoHER with ascorbate. Only the active parts are shown to illustrate the suggested mechanism more clearly. (1) The active part of
ascorbate (top) approaches the active part of oxidized monoHER (bottom) due to a p-p interaction and a hydrogen bond. The p-electrons of
ascorbate are used to create a new bond. The C3 of ascorbate will most likely attack the C39 of the monoHER quinone because it is more electron
deficient than the C49 according to Spartan ‘06. (2) After the attack, a transition state, with an sp3 bond between ascorbate and oxidized monoHER, is
suggested to be formed. (3) This intermediate rapidly decomposes into monoHER and oxidized ascorbate. The driving force of this reaction is the
restoration of the highly conjugated p-system of monoHER.
doi:10.1371/journal.pone.0013880.g006
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(Fig. 5). This is reflected by a LUMO of oxidized quercetin
(0.0605 kJ/mol) that is substantially lower than that of oxidized
monoHER (42.6 kJ/mol). Pearson’s HSAB concept assigns the
terms ‘hard’ or ‘soft’ to chemical species to explain or predict the
outcome of a chemical reaction [28]. ‘Hard’ applies to
electrophiles (the reactants that accept binding electrons) that
have LUMO of high energy or nucleophiles (the reactants that
donate binding electrons) with a low HOMO energy. ‘Soft’, on the
other hand, applies to electrophiles with a low LUMO value or
nucleophiles with a high HOMO value. According to the HSAB
concept, hard electrophiles react faster and form stronger bonds
with hard nucleophiles, whereas soft electrophiles react faster and
from stronger bonds with soft nucleophiles.
Based on their LUMO values, oxidized quercetin is a softer
electrophile than oxidized monoHER. The reaction of GSH with
both oxidized monoHER and quercetin is a Michael addition in
which GSH acts as a nucleophile. The reaction with ascorbate is a
redox reaction in which ascorbate finally donates two electrons to
the oxidized products. GSH is a relatively soft nucleophile
(HOMO value of 21.35 kJ/mol) compared to ascorbate (HOMO
value of 2394 kJ/mol). This can explain the preferential reaction
of the soft electrophile, oxidized quercetin, with thiols over
ascorbate. Oxidized monoHER, on the other hand, is a harder
electrophile than oxidized quercetin explaining its preference for
the harder nucleophile ascorbate over GSH. Moreover, as
depicted in Fig. 6A, the active part of ascorbate can approach
the active part of oxidized monoHER by a hydrogen bond and a
p-p interaction between ascorbate and the ortho-quinone. The
reaction between oxidized monoHER and ascorbate is presented
step by step in Fig. 6B.
Based on our findings, the following concept is proposed.
Flavonoids easily pick up the reactivity of radicals due to their
superior scavenging activity. This reactivity is directed in different
ways by the two flavonoids studied (Fig. 7). Quercetin directs this
reactivity towards thiols. Conjugation of oxidized quercetin with
GSH is primarily a cellular defense mechanism to alleviate the
harmful consequences of the reactive quinone metabolite [32].
However, this will reduce GSH levels and thus weakens the
endogenous antioxidant network. Moreover, in e.g. blood plasma,
where GSH is practically absent, or when GSH has been depleted,
oxidized quercetin will react with protein thiols. This causes
toxicity such as increased membrane permeability [33] or
impaired functioning of enzymes that contain a critical thiol-
group [34,35]. In contrast to quercetin, monoHER preferentially
directs its acquired reactivity towards ascorbate. In human blood
plasma, oxidized monoHER, contrary to oxidized quercetin, does
not react with plasma protein thiols. Ascorbate present in plasma
reduces oxidized monoHER to the parent compound and prevents
that oxidized monoHER reacts with thiols. The oxidized ascorbate
formed in this recycling of monoHER can also be regenerated in
the network, e.g. by dehydroascorbate reductase that uses NADH
as cofactor. In this way, the reactivity is completely neutralized
and the antioxidant network is restored. Thus, the advantage of
monoHER is that it can function as a catalyst that safely channels
the reactivity of radicals into the endogenous antioxidant network.
This advantage might have been involved in the superior effect of
monoHER over other structurally related flavonoids [36] in our
screening procedure for protection against doxorubicin-induced
cardiotoxicity. To conclude, our study demonstrates that struc-
turally related flavonoids, belonging to the same subgroup and
displaying a comparable radical scavenging activity, can have a
different impact on health.
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